Chengdu Daily | Mark, Chief Scientist of Chengdu Enterprises: Matchmaker to Accelerate Chengdu Enterprises' Going Global

2024-07-12 14:50

Report source: Chengdu Daily

2024712110409018.png

share
WeChat
Facebook
X
LinkedIn
Group Information
Prev Milestones | Phase III clinical enrollment of MAXVAX recombinant herpes zoster vaccine (CHO cells)
Next The first domestically developed recombinant respiratory syncytial virus vaccine (CHO cells) has been approved for clinical use!
Phone
+86-21-68403318
QQ
1905311766
WeChet
WeChet
Scan Code
On-Line
Submit